Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
儿童疾病的发病机制、靶向治疗和新疫苗
基本信息
- 批准号:10613453
- 负责人:
- 金额:$ 44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-02-08 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAptitudeAreaCancer BiologyChildhoodCollaborationsCommunicable DiseasesCore FacilityCoupledDiabetes MellitusDiseaseElementsEnvironmentEvaluationFacultyFundingFutureGenetic MedicineGenomic medicineGoalsGrantGroup MeetingsHealth systemHeart DiseasesHospitalsInstitutionInternationalLeadershipLearningLung diseasesMentored Clinical Scientist Development ProgramMentorsMentorshipMetabolismMolecularObesityPathogenesisPhysiciansPositioning AttributeResearchResearch PersonnelResearch Project GrantsResourcesScientistTimeTrainingTraining ProgramsUnderrepresented MinorityUnited States National Institutes of Healthcardiogenesiscareercareer developmentcollaborative environmentdistractionemerging pathogenlaboratory facilitylung developmentmedical schoolsmeetingsmultidisciplinarynervous system disordernext generationnovel vaccinespediatric departmentpediatricianprogramsresearch and developmentresearch facilitytargeted treatmenttherapeutic targettherapeutic vaccinetraining opportunitytranslational physician
项目摘要
Project Summary
The goal of this renewal application is to continue our K12 training program for early career pediatricians with
both the aptitude and passion to become the next generation of basic and translational physician scientists. The
results of our first funding cycle have been excellent, and lessons learned are incorporated to further strengthen
the program. The overarching theme for the program is elucidation of the molecular and cellular pathogenesis
of childhood diseases, leading to identification of therapeutic targets. Our focus is career development in the
following areas where Vanderbilt has internationally recognized programs of discovery combined with a record
of excellence in research mentorship: 1) Lung Disease and Development, 2) Heart Disease and Development;
3) Obesity and Metabolism (including diabetes) 4) Neurological Disorders; 5) Cancer Biology, 6) Genetics and
Genomic Medicine, and 7) Infectious Diseases, including emerging pathogens. The program offers an integrated
pediatric department and medical school training program for four pediatric K12 scholars to receive up to three
years of support that includes intense scientific mentorship and personalized career development. The scholars
will have access to a cadre of well-established faculty including 33 carefully selected senior investigators, all with
sustained NIH funding coupled with a successful track record of mentoring early career scholars. Also, we have
selected 8 pediatric ‘next generation mentors’, with K or early R01 funding that will be well positioned for full
mentorship in the future. The Department of Pediatrics is fully integrated into the Vanderbilt School of Medicine
and health system, a leading NIH funded academic medical center. All departments, hospitals, research
laboratories and core facilities reside on a single campus offering an integrated research environment for
scholars. Through multiple training grants, there is a strong pipeline of future K12 scholars. Program leadership
will also conduct a national search to identify a group of K12 scholars, including underrepresented minorities,
that will thrive in this collaborative environment. Each scholar will have an individualized training program
developed by the PI and training directors in collaboration with a multidisciplinary mentorship team and will be
supported by a broad array of institutional and departmental resources. The primary focus for each scholar will
be their mentored research project, but they will have opportunities to participate in an array of training
opportunities to support their research and career development goals. To avoid distraction from research time,
we will carefully define required activities from optional program opportunities. Required elements include weekly
attendance at lab meetings and with their primary mentor, monthly group meetings with program leaders, six-
monthly scholar oversight committee meetings, and annual evaluations of scholars and program. They will also
have confidential face-to-face meetings with two outside advisors (Drs. Arnold Strauss and George Dover).
These plans provide an optimal environment for developing the next generation of pediatric physician scientists.
项目摘要
此续签申请的目的是继续为早期职业儿科医生的K12培训计划
成为下一代基本和翻译的物理科学家的能力和热情。这
我们的第一个融资周期的结果非常出色,并且学习了经验教训以进一步加强
该程序。该程序的总体主题是阐明分子和细胞发病机理
儿童疾病,导致治疗靶标的鉴定。我们的重点是职业发展
范德比尔特(Vanderbilt)拥有国际认可的发现计划以及记录的领域
卓越研究心态:1)肺部疾病与发育,2)心脏病与发育;
3)肥胖和代谢(包括糖尿病)4)神经系统疾病; 5)癌症生物学,6)遗传学和
基因组医学和7)传染病,包括新兴病原体。该程序提供了一个集成的
针对四个儿科K12学者的儿科部门和医学院培训计划可获得多达三个
多年的支持,包括激烈的科学心态和个性化的职业发展。学者
将可以进入一名成熟的教职员工,其中包括33位精心挑选的高级调查员
持续的NIH资金以及成功的早期职业学者的成功记录。另外,我们有
选定的8个儿科“下一代导师”,具有K或早期R01资金,可以很好地适应
未来的遗产。儿科部已完全纳入范德比尔特医学院
和卫生系统,领先的NIH资助的学术医疗中心。所有部门,医院,研究
实验室和核心设施居住在一个校园中,为综合研究环境提供
学者。通过多个培训补助金,有很强的未来K12学者的渠道。计划领导
还将进行全国搜索,以确定一组K12学者,包括代表性不足的少数民族,
这将在这个协作环境中蓬勃发展。每所学校都会有个性化的培训计划
由PI和培训导演与多学科心态团队合作开发,将是
得到一系列机构和部门资源的支持。每所学校的主要重点将
成为他们的指导研究项目,但他们将有机会参加一系列培训
支持他们的研究和职业发展目标的机会。为了避免研究时间分散注意力,
我们将仔细定义可选计划机会所需的活动。所需的元素包括每周
参加实验室会议以及其主要导师,每月与计划负责人的小组会议,六
每月学校监督委员会会议,以及对学者和计划的年度评估。他们也会
与两名外部顾问(Arnold Strauss博士和George Dover博士)进行机密面对面的会议。
这些计划为发展下一代儿科物理科学家提供了最佳的环境。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael R. DeBaun其他文献
Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease
- DOI:
10.1182/bloodadvances.2024014078 - 发表时间:
2024-12-10 - 期刊:
- 影响因子:
- 作者:
Tami D. John;Mark C. Walters;Hemalatha G. Rangarajan;Mahvish Q. Rahim;Christopher McKinney;Catherine M. Bollard;Ghada Abusin;Mary Eapen;Adetola A. Kassim;Michael R. DeBaun - 通讯作者:
Michael R. DeBaun
Evaluation of hemoglobin S percent threshold to prevent severe pain events: a secondary analysis of the SIT trial
- DOI:
10.1182/bloodadvances.2024013216 - 发表时间:
2024-11-26 - 期刊:
- 影响因子:
- 作者:
Jose Mejias;Alejandro R. Gonzalez-Barreto;Mark Rodeghier;Michael R. DeBaun - 通讯作者:
Michael R. DeBaun
Rationale and Design of a Randomized Controlled Double-Blind Internal Pilot Trial for Prevention of Recurrent Ischemic Priapism in Men with Sickle Cell Disease (PIN Trial)
- DOI:
10.1182/blood-2022-167023 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Ibrahim Musa Idris;Aminu Abba Yusuf;Ismail Isa Ismail;Awwal Musa Borodo;Mustapha Shuaibu Hikima;Shehu Kana;Sani A Aji;Aisha Kuliya_Gwarzo;Mohammad Kabir;Jamil Aliyu Galadanci;Rukayya Alkassim;Nafiu Hussain;Mark Rodeghier;Aurthur Burnett;Michael R. DeBaun - 通讯作者:
Michael R. DeBaun
The Importance of Screening for Food Insecurity in Children with Sickle Cell Anemia: An Ancillary Study to the Severe Acute Malnutrition Feasibility Trial in Nigeria
- DOI:
10.1182/blood-2023-182833 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Gabriela Ramirez Cuebas;Shehu Umar Abdullahi;Safiya Gambo;Hassan Adam Murtala;Halima Kabir;Khadija A. Shamsu;Garba Gwarzo;Sari A Acra;Virginia Stallings;Mark Rodeghier;Michael R. DeBaun;Lauren J Klein - 通讯作者:
Lauren J Klein
No Specific Factors Associated with Risk of Readmission for Rebound Pain in Children with Sickle Cell Disease and Asthma Treated with Systemic Corticosteroids
- DOI:
10.1182/blood-2022-167093 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Reema Kashif;Mark Rodeghier;Shaina M Willen;Michael R. DeBaun;Evans Machogu - 通讯作者:
Evans Machogu
Michael R. DeBaun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael R. DeBaun', 18)}}的其他基金
Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease
镰状细胞病患者治疗后与不良长期健康结果相关的临床和遗传风险因素
- 批准号:
10596076 - 财政年份:2021
- 资助金额:
$ 44万 - 项目类别:
Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease
镰状细胞病患者治疗后与不良长期健康结果相关的临床和遗传风险因素
- 批准号:
10154363 - 财政年份:2021
- 资助金额:
$ 44万 - 项目类别:
Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease
镰状细胞病患者治疗后与不良长期健康结果相关的临床和遗传风险因素
- 批准号:
10371225 - 财政年份:2021
- 资助金额:
$ 44万 - 项目类别:
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease
镰状细胞病急性肺损伤的细胞和分子机制
- 批准号:
8468275 - 财政年份:2013
- 资助金额:
$ 44万 - 项目类别:
Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia
孟鲁司特治疗镰状细胞性贫血的 2 期研究
- 批准号:
8727301 - 财政年份:2013
- 资助金额:
$ 44万 - 项目类别:
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease
镰状细胞病急性肺损伤的细胞和分子机制
- 批准号:
9069964 - 财政年份:2013
- 资助金额:
$ 44万 - 项目类别:
Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia
孟鲁司特治疗镰状细胞性贫血的 2 期研究
- 批准号:
9405682 - 财政年份:2013
- 资助金额:
$ 44万 - 项目类别:
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease
镰状细胞病急性肺损伤的细胞和分子机制
- 批准号:
8722610 - 财政年份:2013
- 资助金额:
$ 44万 - 项目类别:
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease
镰状细胞病急性肺损伤的细胞和分子机制
- 批准号:
8999245 - 财政年份:2013
- 资助金额:
$ 44万 - 项目类别:
Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia
孟鲁司特治疗镰状细胞性贫血的 2 期研究
- 批准号:
8568575 - 财政年份:2013
- 资助金额:
$ 44万 - 项目类别:
相似国自然基金
人文领导:概念、影响机制研究及理论建构
- 批准号:72372080
- 批准年份:2023
- 资助金额:41.00 万元
- 项目类别:面上项目
善于休息才能善于工作:基于内隐情绪调节视角的心理脱离优化机制研究
- 批准号:72001186
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
养精蓄锐才能雷厉风行?——恢复体验对工作拖延行为的动态影响机制研究
- 批准号:71802053
- 批准年份:2018
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
普通高中拔尖学生培养的理论模型与实践模式创新:基于学生发展跟踪数据库的研究
- 批准号:71373081
- 批准年份:2013
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
Vanderbilt Stimulating Access to Research in Residency (V-StARR)
范德比尔特促进住院医师研究机会 (V-StARR)
- 批准号:
10591987 - 财政年份:2023
- 资助金额:
$ 44万 - 项目类别:
Vanderbilt Stimulating Access to Research in Residency (V-StARR)
范德比尔特促进住院医师研究机会 (V-StARR)
- 批准号:
10201735 - 财政年份:2018
- 资助金额:
$ 44万 - 项目类别:
Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
儿童疾病的发病机制、靶向治疗和新疫苗
- 批准号:
10372216 - 财政年份:2016
- 资助金额:
$ 44万 - 项目类别:
Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
儿童疾病的发病机制、靶向治疗和新疫苗
- 批准号:
10225917 - 财政年份:2016
- 资助金额:
$ 44万 - 项目类别: